Catalyst Wire Dossier Catalyst Wire Dossier

TAK-085

· Takeda Pharmaceutical Company
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TAK-085, covering 2016-09-20 to 2016-09-20. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of TAK-085 in Participants With Hypertriglyceridemia [Phase 3]

See pricing